Skip to main content
Equibles

Woodline Partners LP

Position in REPL — Replimune Group, Inc.

CIK 1784547 San Francisco, CA
Back to REPL Full portfolio

Position in REPL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,119,063
-$795,495 QoQ
Shares Held
191,424
-49.8% QoQ
Ownership
0.203%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#46
of 199 holders
Holding Since
Dec 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. REPL ranks #168 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 2,002,863 $375,096,182
2 PTGX
Protagonist Therapeutics, Inc
 1,414,173 $173,349,326
3 TNGX
Tango Therapeutics, Inc.
 4,000,567 $125,057,724
4 BHVN
Biohaven Ltd.
 7,660,280 $113,984,966
5 COGT
Cogent Biosciences, Inc.
 2,603,162 $100,742,369
6 CYTK
Cytokinetics Inc
 1,100,708 $93,769,314
7 RCUS
Arcus Biosciences, Inc.
 3,007,798 $92,730,412
8 ROIV
Roivant Sciences Ltd.
 2,500,673 $88,498,817

All Filings in REPL

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,119,063 191,424
2026-03-31 $2,914,558 380,988
2025-12-31 $5,550,003 570,988
2025-09-30 $3,586,589 855,988
2025-06-30 $7,952,128 855,988
2025-03-31 $8,338,570 855,238
2024-12-31 $10,345,681 854,309
2024-09-30 $3,649,055 332,943
2024-06-30 $2,642,598 293,622
2024-03-31 $2,398,891 293,622
2023-12-31 $2,475,233 293,622
2023-09-30 $5,023,872 293,622
2023-06-30 $6,385,523 275,001
2023-03-31 $5,507,271 311,850
2020-12-31 $2,069,790 54,254